Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Michael

Showing results (11-20 of 1,215) with videos related to

Pageof 122
Sort By:
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|October 9, 2012
Commentary on "Incisional hernia rate may increase after single-port cholecystectomy"L Michael Brunt
Journal of Clinical Pharmacology|December 18, 2007
Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blockerL Michael Prisant
The Journal of Urology|November 7, 2006
The case for adjuvant therapy for prostate cancerL Michael Glodé
Bulletin of the American College of Surgeons|December 17, 2014
Celebrating a decade of innovation in surgical educationL Michael Brunt
Journal of Clinical Hypertension (Greenwich, Conn.)|April 3, 2002
Transdermal clonidine skin reactionsL Michael Prisant
JAMA|April 18, 1998
Protective effect of an SDF-1 variant in HIV disease: abstract and commentaryN L Michael
Immunotargets and Therapy|July 30, 2016
Current perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptorsL Michael Thomas
Managed Care (Langhorne, Pa.)|September 16, 2003
Fixed low-dose combination therapy: current recommendationsL Michael Prisant
Clinical Cardiology|January 15, 2009
Target-organ protection with combination renin-angiotensin-system blockadeL Michael Prisantmd
Oncology (Williston Park, N.Y.)|June 21, 2015
Progress in Prostate Cancer (at Last!)L Michael Glodé
Pageof 122

Showing results (11-20 of 1,215) with videos related to

Sort By:
Pageof 122
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|October 9, 2012
Commentary on "Incisional hernia rate may increase after single-port cholecystectomy"L Michael Brunt
Journal of Clinical Pharmacology|December 18, 2007
Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blockerL Michael Prisant
The Journal of Urology|November 7, 2006
The case for adjuvant therapy for prostate cancerL Michael Glodé
Bulletin of the American College of Surgeons|December 17, 2014
Celebrating a decade of innovation in surgical educationL Michael Brunt
Journal of Clinical Hypertension (Greenwich, Conn.)|April 3, 2002
Transdermal clonidine skin reactionsL Michael Prisant
JAMA|April 18, 1998
Protective effect of an SDF-1 variant in HIV disease: abstract and commentaryN L Michael
Immunotargets and Therapy|July 30, 2016
Current perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptorsL Michael Thomas
Managed Care (Langhorne, Pa.)|September 16, 2003
Fixed low-dose combination therapy: current recommendationsL Michael Prisant
Clinical Cardiology|January 15, 2009
Target-organ protection with combination renin-angiotensin-system blockadeL Michael Prisantmd
Oncology (Williston Park, N.Y.)|June 21, 2015
Progress in Prostate Cancer (at Last!)L Michael Glodé
Pageof 122